Treatment FAQ

which drugs are considered first line drugs for the treatment of heart failure

by Leon Weimann Published 2 years ago Updated 2 years ago
image

First-line drug therapy for all patients with HFrEF should include an angiotensin-converting enzyme (ACE) inhibitor
ACE) inhibitor
Data synthesis: Important adverse effects of ACE inhibitors include first-dose hypotension, renal dysfunction, hyperkalemia, and cough. Less common adverse effects include angioedema, hepatotoxicity. Skin rashes, and dysgeusia.
https://pubmed.ncbi.nlm.nih.gov › ...
and beta blocker
. These medications have been shown to decrease morbidity and mortality.

Medication

Surgery or other procedures for heart failure may include:

  • Coronary bypass surgery. If severely blocked arteries are causing your heart failure, your doctor may recommend coronary artery bypass surgery. ...
  • Heart valve repair or replacement. ...
  • Implantable cardioverter-defibrillators (ICDs). ...
  • Cardiac resynchronization therapy (CRT). ...
  • Ventricular assist devices (VADs). ...
  • Heart transplant. ...

Procedures

  • Yancy CW, Jessup M, Bozkurt B, et al. ...
  • Oeing CU, Tschöpe C, Pieske B. ...
  • McMurray JJ, Packer M, Desai AS, et al. ...
  • Yandrapalli S, Aronow WS, Mondal P, Chabbott DR. ...
  • Chandra A, Lewis EF, Claggett BL, et al. ...
  • Miners JS, Barua N, Kehoe PG, et al. ...
  • Dawson LA, Maitland NJ, Turner AJ, Usmani BA. ...
  • Smollich M, Götte M, Yip GW, et al. ...

More items...

Nutrition

has accepted and filed the company’s New Drug Application (NDA) for omecamtiv mecarbil, an investigational, selective, small molecule cardiac myosin activator, for the treatment of heart failure with reduced ejection fraction (HFrEF). The FDA assigned ...

What is the best medicine for heart failure?

  • Shortness of breath with exertion or at rest
  • Decreased exercise tolerance
  • Fatigue
  • Chest discomfort
  • Swelling in the lower extremities
  • Shortness of breath lying flat

What are the new medications for heart failure?

What is the latest treatment for heart failure?

How to diagnose HFrEF?

image

What is the drug of choice for heart failure?

There are many different types of diuretic, but the most widely used for heart failure are furosemide (also called frusemide) and bumetanide. Possible side effects of diuretics include dehydration and reduced levels of sodium and potassium in the blood.

What is the best treatment for heart failure?

In heart failure, surgery may sometimes prevent further damage to the heart and improve the heart's function. Procedures used include: Coronary artery bypass grafting surgery. The most common surgery for heart failure caused by coronary artery disease is bypass surgery.

Which 5 classes of drugs are used in the management of heart failure?

Five types of drugs were considered as the agents of choice in the treatment of chronic heart failure: angiotensin-converting enzyme (ACE) inhibitors, β-adrenoceptor antagonists (blockers), potassium sparing diuretic (spironolactone), cardiac glycosides, and diuretics other than the potassium-sparing class.

What is the first line treatment for heart failure?

After a patient has been diagnosed with a type, stage, and class, treatment can be determined. First-line drug therapy for all patients with HFrEF should include an angiotensin-converting enzyme (ACE) inhibitor and beta blocker. These medications have been shown to decrease morbidity and mortality.

What is the latest treatment for heart failure?

Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets for adults with heart failure with reduced ejection fraction to reduce the risk of cardiovascular death and hospitalization for heart failure.

Which one of the following is the drug of choice in patient with heart failure with a main symptom of rapid fatigue?

Diuretics remain the most commonly administered agent for AHF. Intravenous furosemide (or equivalent) can provide rapid symptom relief as well as decrease the underlying volume overload.

Which classes of medications are currently used as first line treatments for heart failure select all that apply?

ACE inhibitors (ACEIs), ARBs, beta-blockers, MRAs and diuretics form the basis of first-line pharmacological management of left ventricular systolic heart failure (HFrEF). Treatment doses should be increased to those shown to be of benefit in the major trials or to the highest tolerated doses.

Can a heart recover from heart failure?

There is no cure for heart failure. Damage to your heart muscle may improve but will not go away. There are many causes of heart failure. Common causes of heart failure are coronary artery disease, heart valve disease, high blood pressure and cardiomyopathy.

Can heart failure go back to normal?

Is there a cure for Heart Failure? Heart Failure is a chronic condition that in most cases cannot be cured; however, it can be managed. For most people with Heart Failure, management means self management: taking medications and making positive lifestyle changes.

Can heart failure improve?

Heart failure is a chronic disease needing lifelong management. However, with treatment, signs and symptoms of heart failure can improve, and the heart sometimes becomes stronger. Doctors sometimes can correct heart failure by treating the underlying cause.

Can you reverse heart failure?

Although heart failure is a serious condition that progressively gets worse over time, certain cases can be reversed with treatment. Even when the heart muscle is impaired, there are a number of treatments that can relieve symptoms and stop or slow the gradual worsening of the condition.

What is the new pharmacological therapy for heart failure?

The new guidelines focused on two new classes of medications: an angiotensin receptor-neprilysin inhibitor (ARNI) (valsartan/sacubitril [Entresto, Novartis]) and a sinoatrial node modulator (ivabradine [Corlanor, Amgen]). A recent study found valsartan/sacubitril to be superior to the ACE inhibitor enalapril when added to standard therapy, including a beta blocker and diuretics, in reducing the risk of death and hospitalization.6Ivabradine also reduced the risk of hospitalization for worsening heart failure and the risk of cardiovascular death.5

How many people have heart failure?

Heart failure (HF) affects more than 6.5 million people in the United States and has a 50% mortality rate within five years of diagnosis.1The lifetime risk of HF at 45 years of age is 30% for white men and 32% for white women.2HF is a progressive disease that can result from any structural or functional changes of the heart, leading to the impairment of ventricular filling or ejection of blood. As a consequence, the heart cannot pump blood fast enough to meet the demands of the body.3Typical symptoms of HF include dyspnea and fatigue. The symptoms that present are usually nonspecific to HF but can lead to the review of more specific signs, such as elevated jugular venous pressure or displacement of the apical impulse, and can guide a practitioner to review radiological data consistent with HF.

What is the difference between ACCF and NYHA?

The NYHA classes focus on exercise capacity and the symptomatic status of the disease, whereas the ACCF/AHA stages evaluate the development and progression of the disease.

How do ACE inhibitors affect myocardium?

ACE inhibitors decrease peripheral resistance and reduce the load on the failing myocardium by inhibiting the conversion of angiotensin I to angiotensin II, thus preventing vasoconstriction and causing relaxation of the vasculature. The efficacy of ACE inhibitors has been proven over several decades. Major trials analyzing ACE inhibitors in HFrEF have utilized them in addition to standards of care such as digoxin, vasodilators, loop diuretics, potassium-sparing diuretics, and beta blockers.7–10The CONSENSUS trial, which compared enalapril with placebo in addition to standard of care, showed that enalapril reduced overall mortality risk by 27% and significantly decreased the number of patients with HFrEF progression.7The SOLVD trial demonstrated that, compared with placebo, treatment with enalapril over the course of three years prevented 50 premature deaths and 350 hospitalizations per 1,000 patients.8Collectively, these trials suggest that ACE inhibitors, when taken concurrently with other HFrEF medications, provide significant reductions in morbidity and mortality. These benefits have been shown to remain clinically significant throughout long courses of therapy.10

What class of HF is no symptoms at rest?

Class II : No symptoms at rest, but ordinary physical activities cause HF symptoms

What is the gold standard for HF diagnosis?

Imaging plays an important role in the diagnosis of HF, with echocardiography being the gold standard. Transthoracic echocardiography is the method of choice for assessment of myocardial systolic and diastolic function of both the left and right ventricles.4Once the diagnosis is confirmed, the goals of treatment are to improve clinical status, functional capacity, and quality of life; to prevent hospital admission; and to reduce mortality.

How many classes of HF are there?

In addition to HF type, patients can be assigned a class and/or stage of HF. The New York Heart Association (NYHA) defines four classes of HF:3

What is the treatment for symptomatic heart failure?

Diuretics for treatment of symptomatic heart failure

What is the clinical syndrome of chronic heart failure?

Adult participants with chronic heart failure, defined as a clinical syndrome characterised by breathlessness and fatigue that is caused by an inability of the heart to support an adequate circulation , that may limit exercise tolerance and may lead to pulmonary congestion and peripheral oedema.

What is CHF in medical terms?

Such therapies include angiotensin‐converting enzyme (ACE) inhibitors (Grag 1995; Flather 2000; Yusuf 1991; Yusuf 1992) and more recently beta‐blockers (CIBIS‐II 1999; CIBIS III 2005; COMET 2003; COPERNICUS 2001; MERIT‐HF 2000; Waagstein 1993) reduce mortality and morbidity in chronic heart failure .

Do diuretics help with heart failure?

The available data from several small trials show that in patients with chronic heart failure, conventional diuretics appear to reduce the risk of death and worsening heart failure compared to placebo. Compared to active control, diuretics appear to improve exercise capacity.

Is diuretic a first line treatment for congestive heart failure?

Chronic heart failure is a major cause of morbidity and mortality worldwide. Diuretics are regarded as the first‐line treatment for patients with congestive heart failure since they provide symptomatic relief. The effects of diuretics on disease progression and survival remain unclear.

Can ACE inhibitors be used for heart failure?

Attempts to substitute ACE inhibitors for diuretics can lead to pulmonary and peripheral congestion (Richardson 1987). Diuretics should not be used alone in the treatment of chronic heart failure (ACC/AHA 2009). Even when diuretics are successful in controlling symptoms and fluid retention, diuretics alone are unable to maintain the clinical stability of patients with chronic heart failure for long periods of time (Richardson 1987). The risk of clinical decompensation can be reduced, however, when diuretics are combined with digoxin, ACE inhibitors, and beta‐blockers (Captopril 1988).

Is ibopamine a sympathomimetic inotropic drug?

There is new evidence on potential harm from use of ibopamine, a sympathomimetic inotropic drug, specifically, death rates and worsening of heart failure have been reported for ibopamine in placebo controlled randomised controlled trials (RCT) (van Valdhuisen 2001). In the light of this new evidence we decided to change our protocol and have excluded RCTs comparing diuretic versus ibopamine.

What are the different types of antihypertensive drugs?

To quantify the mortality and morbidity effects from different first‐line antihypertensive drug classes: thiazides (low‐dose and high‐dose), beta‐blockers, calcium channel blockers, ACE inhibitors, angiotensin II receptor blockers (ARB), and alpha‐blockers, compared to placebo or no treatment.

What is a beta blocker?

Beta‐blockers: Beta‐blockers are competitive antagonists that block the receptor sites for epinephrine (adrenaline) and norepinephrine on adrenergic beta‐receptors. Some block activation of all types of beta‐adrenergic receptors (β1, β2, and β3), and others are selective for one of the three types of beta receptors (Frishman 2005).

How to manage high blood pressure?

High blood pressure should initially be managed with changing life style — eating a healthy diet with less salt, exercising regularly, quitting smoking, and maintaining a healthy weight. When these life‐style changes are not enough, treatment with antihypertensive drugs is recommended. Several different classes of medications are available to reduce blood pressure. The six main drug classes, included in this review, are thiazide diuretics, beta‐blockers, angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers, calcium channel blockers, and alpha blockers.

What databases are used for randomized controlled trials?

The Cochrane Hypertension Information Specialist searched the following databases for randomized controlled trials up to November 2017: the Cochrane Hypertension Specialised Register, the Cochrane Central Register of Controlled Trials ( CENTRAL), MEDLINE (from 1946), Embase (from 1974), the World Health Organization International Clinical Trials Registry Platform , and ClinicalTrials.gov. We contacted authors of relevant papers regarding further published and unpublished work.

What is the effect of alpha blockers?

The primary effect of this inhibition is vasodilation, which decreases peripheral vascular resistance, leading to decreased blood pressure.

What is an ACE inhibitor?

Angiotensin converting enzyme (ACE) inhibitors: ACE inhibitors block the conversion of angiotensin I (AI) to angiotensin II (AII), and thus decrease the actions of angiotensin II. The end result is to lower arteriolar resistance and increase venous capacity; decrease cardiac output, cardiac index, stroke work, and volume; lower resistance in blood vessels in the kidneys; and increase excretion of sodium in the urine. Renin and AI increases in concentration in the blood as a result of negative feedback of the conversion of AI to AII. AII and aldosterone levels decrease. Bradykinin increases, because ACE is also responsible for inactivation of bradykinin.

Do thiazides reduce stroke?

We concluded that most of the evidence demonstrated that first‐line low‐dose thiazides reduced mortality, stroke, and heart attack. No other drug class improved health outcomes better than low‐dose thiazides. Beta‐blockers and high‐dose thiazides were inferior.

image
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9